NASDAQ:LFMD • US53216B1044
The current stock price of LFMD is 4.08 USD. Today LFMD is up by 4.35%. In the past month the price increased by 22.19%. In the past year, price decreased by -34.18%.
ChartMill assigns a technical rating of 1 / 10 to LFMD. When comparing the yearly performance of all stocks, LFMD is a bad performer in the overall market: 77.45% of all stocks are doing better.
ChartMill assigns a fundamental rating of 3 / 10 to LFMD. While LFMD seems to be doing ok healthwise, there are quite some concerns on its profitability.
On March 9, 2026 LFMD reported an EPS of -0.04 and a revenue of 46.87M. The company missed EPS expectations (-17.66% surprise) and missed revenue expectations (-1.92% surprise).
14 analysts have analysed LFMD and the average price target is 9.44 USD. This implies a price increase of 131.25% is expected in the next year compared to the current price of 4.08.
For the next year, analysts expect an EPS growth of 60.16% and a revenue growth -5.36% for LFMD
Over the last trailing twelve months LFMD reported a non-GAAP Earnings per Share(EPS) of -0.16. The EPS increased by 70.37% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -11.68% | ||
| ROE | -586.53% | ||
| Debt/Equity | 0 |
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| VEEV | VEEVA SYSTEMS INC-CLASS A | 21.33 | 31.181B | ||
| WAY | WAYSTAR HOLDING CORP | 14.76 | 4.756B | ||
| DOCS | DOXIMITY INC-CLASS A | 14.65 | 4.577B | ||
| HTFL | HEARTFLOW INC | N/A | 1.924B | ||
| LFMDP | LIFEMD INC - LFMD 8 7/8 PERP | N/A | 1.114B | ||
| CERT | CERTARA INC | 13.39 | 1.103B | ||
| CCLDO | CARECLOUD INC - CCLD 8 3/4 PERP | 227.41 | 1.085B | ||
| TDOC | TELADOC HEALTH INC | N/A | 993.688M | ||
| SDGR | SCHRODINGER INC | N/A | 932.473M | ||
| GDRX | GOODRX HOLDINGS INC-CLASS A | 6.13 | 822.168M | ||
| PHR | PHREESIA INC | 17.24 | 708.407M | ||
| HSTM | HEALTHSTREAM INC | 26.64 | 630.653M | ||
| EVH | EVOLENT HEALTH INC - A | 10.93 | 342.735M |
View all stocks in the Health Care Technology Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
LifeMD, Inc. is a telehealth company, which engages in offering a portfolio of direct-to-patient products and services. The company is headquartered in New York City, New York and currently employs 304 full-time employees. The company went IPO on 2001-07-11. The firm offers telemedicine, access to laboratory and pharmacy services, and specialized treatment across 200 conditions, including primary care, men’s and women’s health, mental health, and weight management. Its Telehealth platform is end-to-end virtual healthcare directly to consumers and through select enterprise partnerships. In addition, the Company is focused on developing its Rex MD product portfolio, which is primarily focused on asynchronous men’s healthcare, e-pharmacy solutions, and men’s hormonal health. The firm owns a vertically integrated, proprietary digital care platform, a 50-state affiliated medical group, a state-of-the-art affiliated compounding pharmacy, and a United States based patient care center.
IPO: 2001-07-11
LIFEMD INC
236 Fifth Avenue, Suite 400
New York City NEW YORK 10022 US
CEO: Justin Schreiber
Employees: 304
Phone: 18663515907
LifeMD, Inc. is a telehealth company, which engages in offering a portfolio of direct-to-patient products and services. The company is headquartered in New York City, New York and currently employs 304 full-time employees. The company went IPO on 2001-07-11. The firm offers telemedicine, access to laboratory and pharmacy services, and specialized treatment across 200 conditions, including primary care, men’s and women’s health, mental health, and weight management. Its Telehealth platform is end-to-end virtual healthcare directly to consumers and through select enterprise partnerships. In addition, the Company is focused on developing its Rex MD product portfolio, which is primarily focused on asynchronous men’s healthcare, e-pharmacy solutions, and men’s hormonal health. The firm owns a vertically integrated, proprietary digital care platform, a 50-state affiliated medical group, a state-of-the-art affiliated compounding pharmacy, and a United States based patient care center.
The current stock price of LFMD is 4.08 USD. The price increased by 4.35% in the last trading session.
LFMD does not pay a dividend.
LFMD has a ChartMill Technical rating of 1 out of 10 and a ChartMill Fundamental rating of 3 out of 10.
LFMD stock is listed on the Nasdaq exchange.
The Revenue of LIFEMD INC (LFMD) is expected to decline by -5.36% in the next year. Check the estimates tab for more information on the EPS, Sales, EBIT and EBITDA future analyst estimates.
The outstanding short interest for LIFEMD INC (LFMD) is 14.46% of its float.